Gene chip concept stocks:
Star Lake Technology (600866) : Shanghai Boxing Gene Chip Co., LTD., which owns 50% of the company, is the modern biochip high-tech enterprise with the largest investment scale in the gene chip industry in China, and the only professional company that produces and supplies commercial gene chip products on a scale in China. Its core technology has the world's leading level.
Zhongxin Pharmaceutical (600329) : Participated in Tianjin Biochip Technology Co., LTD. (26.4% of the company), which is mainly engaged in the research and development of microbial detection chips, genomics and functional genomics, and is one of the five biochip research and development bases funded by the National 863 program during the \"Tenth Five-Year Plan\" period, and is the only base dedicated to the research and development of pathogenic microorganisms detection biochips. It has invested in the construction of four modern biotechnology research platforms: genomics, functional genomics, bioinformatics and biochips. Since its inception, the company has introduced the chip analysis platform of the global biochip pioneer Angfei Gene Chip Company of the United States, and is the only partner and one of the three authorized technology service providers of the latter's \"Great Wall of Health\" program in China.
Daan Gene (002030) : In 1996, the company took the lead in developing fluorescence quantitative pcr detection technology in China, opening up a new field of gene disease diagnosis. Among the medical institutions that carry out fluorescence quantitative pcr detection in China, 70% have established cooperative relations with the company, and the products have an absolute advantage in the market. Fluorescent quantitative pcr detection technology is the leading direction of the development of gene diagnosis, and the industry in which the company is located has a good development prospect.
Rongzhilian (002642) : Relying on BGI to layout \"Biological Cloud\" : The company early focused on the needs of the biological industry for mass data processing, relying on the accumulated technical advantages in high-performance computing and mass storage, BGI designed, built and maintained biological information supercomputing centers located in Shenzhen and Hong Kong for BGI, and successfully solved the problems of parallel computing and storage of massive data generated by gene sequencing. Bgi now has supercomputing capacity of 157 trillion times per second, data storage capacity of 12.6pb, and gene sequencing capacity ranks first in the world. In June 2011, China's first national gene bank and international science and technology cooperation base two major biotechnology basic platforms settled in BGI. Bgi has launched \"biocloud computing\" services with its powerful data centers, which mainly include services such as Bioinformation Analysis Center (bgicloud), online storage service (bgishare) and Bioinformation Virtual Lab (bgivlab).
Airport Shares (600463) : BGI is very likely to backdoor listing, BGI is one of the founders of airport shares 600463, if backdoor listing, airport shares of course is the best choice.